Lee M. Kaplan - Publications, H-index & Citations

Lee M. Kaplan

the obesity and metabolism institute

73H指数

248论文数

3.5W被引数

收录论文 103

发表时间

Author Correction: Survodutide in adults with obesity and metabolic dysfunction-associated steatotic liver disease: SYNCHRONIZE-MASLD, a randomized, double-blind, placebo-controlled phase 3 trial 作者更正：索沃杜肽在肥胖和代谢功能障碍相关脂肪性肝病成人患者中的应用：SYNCHRONIZE-MASLD，一项随机、双盲、安慰剂对照的3期临床试验

Nature Medicine

IF50

2026-08-25

OAAI

Lee M. Kaplan; Elena Startseva; Carel W. le Roux; Sean Wharton; Biykem Bozkurt; Daniel F. Mazo; Jessica von Schlippenbach; Sandra González Maldonado; Samina Ajaz Hussain; Guy W. Neff; Yaneicy Gonzalez Rojas; Charles Smith; Ramy Younes; Arun J. Sanyal

Survodutide in adults with obesity and metabolic dysfunction-associated steatotic liver disease: SYNCHRONIZE-MASLD, a randomized, double-blind, placebo-controlled phase 3 trial 肥胖和代谢功能障碍相关的脂肪变性肝病成人的Survodutide: synchrone-masld，一项随机，双盲，安慰剂对照的3期试验

Nature Medicine

IF50

2026-06-07

OAAI

International Expert Consensus on Definitions and Management of Weight Recurrence and Suboptimal Response After Metabolic and Bariatric Surgery: A Delphi Study 《代谢与减肥手术后体重复发及疗效不佳的定义与管理：国际专家共识（一项德尔菲研究）》

Surgery for Obesity and Related Diseases

IF3.8

2026-03-17

PREAI

Mélissa V. Wills; Sol Lee; Valentin Mocanu; Yung Lee; Pattharasai Kachornvitaya; Xinlei Zhu; Nasreen Alfaris; Laura Andromalos; Caroline Apovian; Estuardo Behrens; Dieter Birk; Luca Busetto; Anita Courcoulas; David Cummings; Silvia Leite Faria; Omar Ghanem; Sang-Moon Han; Shahzeer Karmali; Lee Kaplan; Lilian Kow

International Journal of Obesity

IF3.8

2026-03-03

OAAI

Magdalena Nowak; Luis Núñez; Tim Pagliaro; Matthew D. Robson; Carlos Duncker; Lee M. Kaplan; Steve B. Heymsfield; Helena Thomaides Brears; Jimmy D. Bell; Louise E. Thomas

Baseline characteristics in the SYNCHRONIZE™-2 randomized phase 3 trial of survodutide, a glucagon receptor/GLP-1 receptor dual agonist, for obesity in people with type 2 diabetes SYNCHRONIZE™-2随机III期临床试验中，survodutide（一种胰高血糖素受体/GLP-1受体双重激动剂）用于2型糖尿病人群肥胖治疗的基线特征。

Diabetes, Obesity and Metabolism

IF0

2025-11-11

OAAI

Sean Wharton MD; Carel W. le Roux MBChB; Biykem Bozkurt MD; Elke Platz MD; Gabriele Bleckert PhD; Samina Ajaz Hussain MD; Martina Brueckmann MD; Elena Startseva MD; Isabel M. Kloer MD; Lee M. Kaplan MD

People With Lowest Physical Functioning Scores Showed Greatest Improvement After Tirzepatide Treatment 最低身体功能评分的人群在Tirzepatide治疗后显示出最大改善。

Obesity

IF4.7

2025-11-04

OAAI

Xuan Li; Dachuang Cao; Helene Sapin; Fangyu Wang; Theresa Hunter Gibble; Nedina Kalezic Raibulet; Max Denning; Lee M. Kaplan

Survodutide for treatment of obesity: Baseline characteristics of participants in a randomized, double-blind, placebo-controlled, phase 3 trial (SYNCHRONIZE™-1)Survodutide治疗肥胖：一项随机、双盲、安慰剂对照的III期试验（SYNCHRONIZE™-1）中参与者的基线特征

Diabetes, Obesity and Metabolism

IF0

2025-11-04

OAAI

Carel W. le Roux MBChB; Sean Wharton MD; Biykem Bozkurt MD; Elke Platz MD; Gabriele Bleckert PhD; Samina Ajaz Hussain MD; Martina Brueckmann MD; Elena Startseva MD; Isabel M. Kloer MD; Lee M. Kaplan MD

Survodutide for the Treatment of Obesity: Baseline characteristics of the SYNCHRONIZE Cardiovascular Outcomes Trial 司美格鲁肽用于肥胖症治疗：SYNCHRONIZE心血管结局试验的基线特征

JACC: Heart Failure

IF0

2025-11-03

PREAI

Elke Platz; Lee M. Kaplan; Carel W. le Roux; Sean Wharton; Svenja Burger; Samina Ajaz Hussain; Martina Brueckmann; Elena Startseva; Constanze Fey; Mikhail N. Kosiborod; Biykem Bozkurt

Retatrutide for the treatment of obesity, obstructive sleep apnea and knee osteoarthritis: Rationale and design of the TRIUMPH registrational clinical trials Retatrutide用于治疗肥胖、阻塞性睡眠呼吸暂停和膝关节骨关节炎：TRIUMPH注册临床试验的原理与设计

Diabetes, Obesity and Metabolism

IF0

2025-10-15

OAAI

Kathryn Giblin MD; Lee M. Kaplan PhD; Virend K. Somers PhD; Carel W. Le Roux PhD; David J. Hunter PhD; Qiwei Wu PhD; Amy Lalonde PhD; Nadia Ahmad MD; Mary Angelyn Bethel MD

Attitudinal factors influencing willingness to use anti-obesity medication in adults with obesity 影响肥胖成年人使用抗肥胖药物意愿的态度因素

CURRENT RESEARCH IN BEHAVIORAL SCIENCES

IF0

2025-09-01

OAAI

Kumar, Rekha; Kan, Hong; Honomichl, Ryan; Kahan, Scott; Gudzune, Kimberly; Sims, Tracy J.; Ard, Jamy; Kaplan, Lee M.; King-Concialdi, Kristen; Drakeley, Sheila; Beusterien, Kathleen

Missing the Target: A Scoping Review of the Use of Percent Weight Loss for Obesity Management 目标缺失：关于体重百分比损失在肥胖管理中应用的概述性综述

Obesity Reviews

IF7.4

2025-06-03

OAAI

Diana Sherifali; Megan Racey; Donna Fitzpatrick-Lewis; Michelle Greenway; Sanjeev Sockalingam; Jun Wada; Soo Huat Teoh; Ian Patton; David Macklin; Elizabeth F. C. van Rossum; Luca Busetto; Deborah Bade Horn; J. D. Patricia Nece; Morgan Emile Gabriel Salmon Leguede; Nicole Pearce; Carel Le Roux; Jamy Ard; Angela S. Alberga; Lee Kaplan; Arya M. Sharma; Sean Wharton

Perceptions of anti-obesity medications among people with obesity and healthcare providers in the US: Findings from the OBSERVE Study 美国人群中肥胖患者与医疗保健提供者对减肥药物的认知：OBSERVE研究的结果

OBESITY

IF4.7

2025-04-24

OAAI

Kaplan, Lee M.; Gudzune, Kimberly; Ard, Jamy; Kumar, Rekha; Ahmad, Nadia N.; Kan, Hong; Sims, Tracy J.; Poon, Jiat Ling; King-Concialdi, Kristen; Beusterien, Kathleen; Drakeley, Sheila; Dunn, Julia P.; Kahan, Scott

Survodutide for treatment of obesity: rationale and design of two randomized phase 3 clinical trials (SYNCHRONIZE™-1 and-2)

OBESITY

IF4.7

2024-11-04

OAAI

Wharton, Sean; le Roux, Carel W.; Kosiborod, Mikhail N.; Platz, Elke; Brueckmann, Martina; Jastreboff, Ania M.; Hussain, Samina Ajaz; Pedersen, Sue D.; Borowska, Luiza; Unseld, Anna; Kloer, Isabel M.; Kaplan, Lee M.

Weight-Reduction Preferences Among OBSERVE Study Participants With Obesity or Overweight: Opportunities for Shared Decision-Making

ENDOCRINE PRACTICE

IF4.6

2024-10-01

OAAI

Gudzune, Kimberly A.; Kaplan, Lee M.; Kahan, Scott; Kumar, Rekha B.; Dunn, Julia P.; Ahmad, Nadia N.; Poon, Jiat Ling; Sims, Tracy J.; Mackie, deMauri S.; Jauregui, Adam K.; Balkaran, Bridget L.; Kan, Hong; Ard, Jamy

Triple hormone receptor agonist retatrutide for metabolic dysfunction-associated steatotic liver disease: a randomized phase 2a trial 三激素受体激动剂瑞他肽治疗代谢功能障碍相关的脂肪性肝病: 一项随机2a期试验

NATURE MEDICINE

IF50

2024-06-10

OAAI

Sanyal, Arun J.; Kaplan, Lee M.; Frias, Juan P.; Brouwers, Bram; Wu, Qiwei; Thomas, Melissa K.; Harris, Charles; Schloot, Nanette C.; Du, Yu; Mather, Kieren J.; Haupt, Axel; Hartman, Mark L.

Antiretrovirals and Weight Change: Weighing the Evidence

CLINICAL INFECTIOUS DISEASES

IF7.3

2024-04-12

PREAI

Wohl, David Alain; Koethe, John R.; Sax, Paul E.; Mccomsey, Grace A.; Kuritzkes, Daniel R.; Moyle, Graeme; Kaplan, Lee; van Wyk, Jean; Campo, Rafael E.; Cohen, Calvin

Triple-Hormone-Receptor Agonist Retatrutide for Obesity - A Phase 2 Trial 三激素受体激动剂瑞他肽治疗肥胖症-2期试验

NEW ENGLAND JOURNAL OF MEDICINE

IF78.5

2023-08-10

325

PREAI

Jastreboff, Ania M. M.; Kaplan, Lee M. M.; Frias, Juan P. P.; Wu, Qiwei; Du, Yu; Gurbuz, Sirel; Coskun, Tamer; Haupt, Axel; Milicevic, Zvonko; Hartman, Mark L. L.

Obstacles and Opportunities in Managing Coexisting Obesity and CKD: Report of a Scientific Workshop Cosponsored by the National Kidney Foundation and The Obesity Society

AMERICAN JOURNAL OF KIDNEY DISEASES

IF8.2

2022-12-01

OAAI

Friedman, Allon N.; Schauer, Philip R.; Beddhu, Srinivasan; Kramer, Holly; le Roux, Carel W.; Purnell, Jonathan Q.; Sunwold, Duane; Tuttle, Katherine R.; Jastreboff, Ania M.; Kaplan, Lee M.

Obstacles and opportunities in managing coexisting obesity and CKD: Report of a scientific workshop cosponsored by the National Kidney Foundation and The Obesity Society

OBESITY

IF4.7

2022-10-21

PREAI

Friedman, Allon N.; Schauer, Philip R.; Beddhu, Srinivasan; Kramer, Holly; le Roux, Carel W.; Purnell, Jonathan Q.; Sunwold, Duane; Tuttle, Katherine R.; Jastreboff, Ania M.; Kaplan, Lee M.

The Obesogenic and Glycemic Effect of Bariatric Surgery in a Family with a Melanocortin 4 Receptor Loss-of-Function Mutation

METABOLITES

IF3.7

2022-05-11

OAAI

Grinbaum, Ronit; Beglaibter, Nahum; Mitrani-Rosenbaum, Stella; Kaplan, Lee M.; Ben-Zvi, Danny

研究方向